Skip to main content

AACR Archives

Grant bolsters kidney cancer immunotherapy research

May. 10, 2018—W. Kimryn Rathmell, MD, PhD, Cornelius Abernathy Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt-Ingram Cancer Center (VICC), has received a grant to research the role of immunosuppression in the tumor microenvironment for kidney cancer.

Read more


Study to test combination therapy for breast cancer

Oct. 26, 2017—Vanderbilt-Ingram Cancer Center (VICC) has received $2.3 million to fund a clinical research trial testing a combination of three immunotherapy compounds for patients with a specific type of advanced breast cancer.

Read more


Project reveals importance of cancer gene mutation testing

Jun. 8, 2017—An international genomic data-sharing consortium has analyzed nearly 19,000 patient genomic records and found that testing of patient tumors for relevant gene mutations often provides a roadmap for the use of effective therapies.

Read more


VICC joins cancer genomic data sharing initiative

Jan. 19, 2017—Vanderbilt-Ingram Cancer Center (VICC) has joined an international consortium of leading cancer centers to share genomic data from patients in an effort to accelerate the pace of cancer research and improve precision medicine.

Read more


VICC investigators in spotlight at AACR conference

May. 19, 2016—A top Vanderbilt-Ingram Cancer Center (VICC) investigator recently met with Vice President Joe Biden regarding the National Cancer Moonshot Initiative, a major national program to identify, fund and accelerate the most promising research leading to cancer cures.

Read more


DISSECTing cell signaling networks

Dec. 14, 2015—Vanderbilt researchers have developed a new method to study cell signaling networks at single-cell resolution.

Read more


Exercise during teen years linked to lowered risk of cancer death later

Aug. 4, 2015—Women who exercised during their teen years were less likely to die from cancer and all other causes during middle-age and later in life, according to a new study by investigators at Vanderbilt University Medical Center and the Shanghai Cancer Institute in China.

Read more


Arteaga, AACR push for cancer research funding

Jul. 9, 2015—Carlos L. Arteaga, M.D., director of the Center for Cancer Targeted Therapies and director of the Breast Cancer Program at Vanderbilt-Ingram Cancer Center (VICC), recently joined other cancer research leaders in a meeting with members of Congress to discuss precision medicine in cancer and the need for continued federal support for cancer research.

Read more


Jansen’s cancer research efforts garner recognition

May. 14, 2015—Valerie Malyvanh Jansen, M.D., Ph.D., a third-year medical oncology fellow, recently received several national awards and grants, as well as a Vanderbilt-Ingram Cancer Center fellowship, in recognition of her translational cancer research.

Read more


VICC cancer research efforts in spotlight at AACR conference

Apr. 30, 2015—Adding an investigational drug to an already approved estrogen blocking therapy appears to be safe and provided clinical benefit for some postmenopausal women with estrogen-positive breast cancer.

Read more


Cancer organizations call for regulation of e-cigarettes

Jan. 15, 2015—Two leading cancer organizations are calling for regulation of e-cigarettes and other electronic nicotine delivery systems (ENDS).

Read more


Cancer progress report calls for added research support

Sep. 25, 2014—There are now approximately 14.5 million cancer survivors in the United States, thanks in large part to advances in cancer research and the development of new anti-cancer therapies.

Read more


Page 1 of 212

Recent Stories from VUMC News and Communications Publications

Brighter days ahead

Vanderbilt Medicine

Brighter days ahead

Community care

Vanderbilt Nurse

Community care

Survive and thrive

Hope

Survive and thrive

Combating cancer disparities is an out-of-office assignment

Momentum

Combating cancer disparities is an out-of-office assignment

more